| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/23/2006 | US7049085 Monoclonal antibody for use in passive immunization against poisoning/intoxication by botulin toxins |
| 05/23/2006 | US7049084 Neuroblastoma cell lines expressing the α2δ subunit of calcium channels and methods therefore |
| 05/23/2006 | US7049083 Methods for identifying modulators of N-type ion channel inactivation |
| 05/23/2006 | US7049082 Methods, products and treatments for diabetes |
| 05/23/2006 | US7049081 Antiproliferative gene |
| 05/23/2006 | US7049080 Process for detecting serine/threonine kinase activity |
| 05/23/2006 | US7049079 Coupling factor 6 inhibitor and potentiator and use thereof |
| 05/23/2006 | US7049078 Apolipoprotein E polymorphism and treatment of alzheimer's disease |
| 05/23/2006 | US7049076 Method for assaying protein—protein interaction |
| 05/23/2006 | US7049074 Methods and compositions for the manipulation and characterization of individual nucleic acid molecules |
| 05/23/2006 | US7049073 Using phosphoramidite compound; biosynthesis |
| 05/23/2006 | US7049072 Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state |
| 05/23/2006 | US7049071 Nucletide sequences coding protein for use as diagnostic tool in the detection of genetic damage |
| 05/23/2006 | US7049070 Detecting variation in nucleotide sequence pattern; obtain nucleotide squences, depolymerize, separate sequences, monitor mobility pattern of nucleotide sequences |
| 05/23/2006 | US7049069 Detection of urogenital disorders in humans; obtain biological sample, monitor cytokine expression, compare to wild type control, evaluate for urogenital disorders |
| 05/23/2006 | US7049067 Human immunodeficiency virus (HIV); which can bind to a specific site of the RNA; amplification; change in fluorescence upon hybridization |
| 05/23/2006 | US7049066 Diagnosis and treatment of myocardial failure |
| 05/23/2006 | US7049064 Generating preferential microoarrays; obtain solid support, incubate with chemical intermediates, recover microarray |
| 05/23/2006 | US7049060 Secreted by hybridoma cell lines; hepatitis C virus (HCV) |
| 05/23/2006 | US7049059 Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression |
| 05/23/2006 | US7048949 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
| 05/23/2006 | US7048906 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 05/23/2006 | US7048903 use of nanotubes attached to macroscale mounting members as nanoscale probes, fabricators and manipulators; all its constituent atoms are covalently bonded in place and are do not move under extreme stress |
| 05/23/2006 | US7048901 production method of the electrical connection structure, and electric wiring; carbon nanotube as the electrode and contacting the electrode with the biopolymer (DNA, RNA, or a protein) then applying an electric current between the electrode and biopolymer |
| 05/23/2006 | US7048890 magnetic detection of binding of biological molecules on a biochip in which a magnetoresistive sensor device measures an areal density of magnetic nanoparticles on a micro-array, the magnetic nanoparticles being directly or indirectly coupled to a target sample |
| 05/23/2006 | US7048856 Filtering blood; medical diagnosis; bioreactor; porous membrane |
| 05/23/2006 | US7047820 Apparatus and method for testing material performance |
| 05/23/2006 | US7047795 Analyzing instrument, analyzing device, and method of manufacturing analyzing instrument |
| 05/23/2006 | CA2335305C A bioluminescence resonance energy transfer (bret) system and its use |
| 05/23/2006 | CA2201865C Laminin chains: diagnostic and therapeutic use |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/18/2006 | WO2006053322A2 Compositions and methods for inferring an adverse effect in response to a drug treatment |
| 05/18/2006 | WO2006053208A1 System and method for determining sample volume in a container |
| 05/18/2006 | WO2006053187A2 Device and method for purification of biological materials |
| 05/18/2006 | WO2006053148A1 Method of detecting the presence and/or progression of cancer |
| 05/18/2006 | WO2006053063A2 Notch-1 assay to detect neurodegenerative diseases |
| 05/18/2006 | WO2006052975A2 Tumor association of mdl-1 and methods |
| 05/18/2006 | WO2006052924A2 Methods and compositions for protein-hydroxy apatite complexes and their application in testing and modulating immunological system including a novel in vitro test for the detection of antibodies against calcium binding protein-hydroxy apatite complexes |
| 05/18/2006 | WO2006052891A1 Analyte identification using electronic devices |
| 05/18/2006 | WO2006052860A2 Modulators of retinol-retinol binding protein (rbp)-transthyretin (ttr) complex formation |
| 05/18/2006 | WO2006052842A2 Methods for diagnosis of myelodysplastic syndromes (mds) |
| 05/18/2006 | WO2006052788A2 Detection of activation of endothelial cells as surrogate marker for angiogenesis |
| 05/18/2006 | WO2006052764A1 Quantitative analysis of a biological sample of unknown quantity |
| 05/18/2006 | WO2006052742A2 Pharmaceutical analysis apparatus and method |
| 05/18/2006 | WO2006052735A2 Fibulin-3 and uses thereof |
| 05/18/2006 | WO2006052718A2 Farnesyltransferase inhibitors for treating sepsis |
| 05/18/2006 | WO2006052682A2 Optical scanning system comprising thermally compensated light emitting diode |
| 05/18/2006 | WO2006052391A2 Heterocyclic inhibitors of ires-mediated translation and methods of use thereof |
| 05/18/2006 | WO2006052351A2 Biological microbeads for various flow cytometric applications |
| 05/18/2006 | WO2006052223A1 Cell culture device |
| 05/18/2006 | WO2006052202A1 An apparatus and method for determining physical parameters in an object using acousto-electric interaction |
| 05/18/2006 | WO2006052000A1 Target protein and target gene in drug designing and screening method |
| 05/18/2006 | WO2006051987A1 Novel drug for inhibiting estrogen-dependent diseases, prostaglandin d (pgd)-dependent gynecological diseases, immunological diseases, cancer and angiogenesis |
| 05/18/2006 | WO2006051951A1 REMEDY FOR DIABETES CONTAINING Cdk5 INHIBITOR |
| 05/18/2006 | WO2006051946A1 Novel polypeptide having protease inhibitory activity |
| 05/18/2006 | WO2006051944A1 Fluorescent protein |
| 05/18/2006 | WO2006051847A1 Method of examining/judging presence of virus infection such as hiv or presence of prion infection by near-infrared spectroscopy and device used in same |
| 05/18/2006 | WO2006051756A1 Method of detecting calmodulin structure change, method of retrieving matter having activity affecting calmodulin structure change |
| 05/18/2006 | WO2006051670A1 Gene expression level standardization method, program, and system |
| 05/18/2006 | WO2006051551A2 Device and method for analysis of a metabolic malady |
| 05/18/2006 | WO2006051548A2 Blood type method system and device |
| 05/18/2006 | WO2006051310A1 Improved method of electrochemical analysis of an analyte |
| 05/18/2006 | WO2006051241A2 Method for coupling non-immunogenic molecules, intermediate compound, final product obtained and uses thereof |
| 05/18/2006 | WO2006051183A1 Method and system for measuring the transparency of a stretchable textile article such as stockings, tights or a sock |
| 05/18/2006 | WO2006051172A1 Method for testing a compound for a therapeutic effect and a diagnostic method |
| 05/18/2006 | WO2006051145A1 Competitive elisa for the detection of gluten hydrolysate and applications thereof |
| 05/18/2006 | WO2006051112A1 Stem cells, method for their purification, identification, and use |
| 05/18/2006 | WO2006050964A2 Indinavir derivatives useful in immunoassay |
| 05/18/2006 | WO2006050949A2 Superagonistic anti-cd28 antibody |
| 05/18/2006 | WO2006050945A2 Tubulin mutation diagnostic |
| 05/18/2006 | WO2006050683A1 Device for the non-invasive measurement of cell signals |
| 05/18/2006 | WO2006050667A1 MONOCLONAL ANTIBODIES AGAINST APOPTOSIS-RELATED ACETYLCHOLINESTERASE (AR-AChE) AND USE THEREOF |
| 05/18/2006 | WO2006050573A1 Method of diagnosing cancer and reagents therefor |
| 05/18/2006 | WO2006050571A1 Chlamydia antigens and uses thereof |
| 05/18/2006 | WO2006038010A3 Detection of breast cancer |
| 05/18/2006 | WO2006036842A3 Methods, systems, and computer program products for hierarchical registration between a blood vessel and tissue surface model for a subject and blood vessel and tissue surface image for the subject |
| 05/18/2006 | WO2006034272A3 An optical sensor and methods of making it |
| 05/18/2006 | WO2006034081A3 Polymers for analyte detection |
| 05/18/2006 | WO2006033675A3 Bacillus anthracis spore specific antobodies |
| 05/18/2006 | WO2006031322A3 Determination of the 3d-structure of an extracellular domain of a b1 g-protein coupled receptor by nmr analysis |
| 05/18/2006 | WO2006031273A3 Cellular phenotype |
| 05/18/2006 | WO2006021888B1 Dihydrofolate reductase inhibition by epigallocatechin gallate compounds |
| 05/18/2006 | WO2006018625A3 Peripheral benzodiazepine receptor independent superoxide generation |
| 05/18/2006 | WO2006008124A3 Molecular diagnostic method and treatment in dementia with lewy bodies |
| 05/18/2006 | WO2006007853A3 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line |
| 05/18/2006 | WO2006007368A3 Biofunctional coatings |
| 05/18/2006 | WO2005124362A3 Method and test kit for diagnosing ischaemic heart damage, in particular the latent, chronic types, by the serological detection of myosin light chain 1 |
| 05/18/2006 | WO2005124354A3 Use of protein ch10 as a marker for breast cancer |
| 05/18/2006 | WO2005123760A3 Treating cancer |
| 05/18/2006 | WO2005118840A3 Diagnostics and therapeutics for diseases associated with kallikrein 10 (klk10) |
| 05/18/2006 | WO2005118640A3 A h+-gated ion channel |
| 05/18/2006 | WO2005117577A3 Model for neurodegenerative disorders |
| 05/18/2006 | WO2005116653A3 Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders |
| 05/18/2006 | WO2005116647A3 System for the evaluation of tracer concentration in a reference tissue and a target region |
| 05/18/2006 | WO2005115400A3 Antibiotic compound |
| 05/18/2006 | WO2005114188A3 Cul4 e3 ligase mediators as regulators of p53 |
| 05/18/2006 | WO2005113787A3 Diagnostics and therapeutics for diseases associated with g protein-dependent receptor kinase 1 (grk1) |
| 05/18/2006 | WO2005113587A3 Gene products expressed differentially in tumors and use thereof |
| 05/18/2006 | WO2005108988A3 Real time method of detecting acute inflammatory conditions |
| 05/18/2006 | WO2005100997A3 Diagnostics and therapeutics for diseases associated with tachykinin receptor 3 (tacr3) |